Literature DB >> 30019995

Genetic polymorphisms of CYP2S1, CYP2J2 and CYP2R1 genes in three Chinese populations: Han, Tibetan and Uighur.

Xing Kang1, Hailong Shi2, Lirong Zhang1, Yanxia Wang1, Tingting Zhang1, Min Han1, Chao Chen1, Huijuan Wang1.   

Abstract

AIM: Cytochrome P450 enzymes CYP2S1, CYP2J2 and CYP2R1 are of interest due to their unknown enzymatic function and disease-specific expression property. The aim of this study was to investigate the genetic variations of CYP2S1, CYP2J2 and CYP2R1 genes, and their polymorphic distribution in different Chinese populations. MATERIALS &
METHODS: All of the exons, exon-intron boundaries and 1 kb 5'-flanking region of the three genes were sequenced in 150 Chinese subjects.
RESULTS: There were 21, 15 and nine genetic variants identified in CYP2S1, CYP2J2 and CYP2R1 genes, respectively. The genetic polymorphisms of CYP2S1 and CYP2J2 showed significant difference. Thr353Ala variant in CYP2S1 protein was predicted to be consistently damaged. The hydrogen bond interactions were decreased in two mutants: Thr353Ala and Cys372Ser. -177C >T in CYP2S1 affected transcription factor EGR1 binding site.
CONCLUSION: This study highlights the importance of genetic polymorphism information on the CYP2S1, CYP2J2  and CYP2R1 genes in Chinese populations.

Entities:  

Keywords:  genetic polymorphism; homology modeling; linkage disequilibrium

Mesh:

Substances:

Year:  2018        PMID: 30019995     DOI: 10.2217/pgs-2018-0063

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  1 in total

1.  Polymorphisms of genes related to vitamin D metabolism and transportation and its relationship with the risk of osteoporosis: protocol for a multicentre prospective cohort study in China.

Authors:  Jing Wang; Bing Shu; Chen-Guang Li; Xing-Wen Xie; Bo-Lai Chen; Xin-Chao Lin; Xu Wei; Liang Wang; Xiang-Yang Leng; Ying-Jie Zhou; Pei-Zhan Chen; Yu-Ren Tao; Yong Zhou; Yan Zhang; Xue-Jun Cui; Sheng Lu; Hui Wang; Qi Shi; Yong-Jun Wang
Journal:  BMJ Open       Date:  2019-11-24       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.